Skip to content

Advertisement

  • Meeting abstract
  • Open Access

Which treatment for upper respiratory tract infections?

Italian Journal of Pediatrics201541(Suppl 2):A31

https://doi.org/10.1186/1824-7288-41-S2-A31

Published: 30 September 2015

Keywords

IbuprofenAmoxicillinCeftriaxoneAcute Otitis MediumPharyngitis

Upper Respiratory Tract Infections (URTIs) include rhinosinusitis, acute otitis media (AOM), pharyngotonsillitis and laryngitis [1]. Viruses are responsible for the great majority of URTIs therefore antimicrobial treatment is not always required [2]. Paracetamol (7-15 mg/kg/dose) and ibuprofen (4-10 mg/kg/dose) are considered as the standard analgesics [3].

Regarding rhinosinusitis, clinicians should suspect a bacterial etiology when a child presents with persistent, worsening or severe illness. S. pneumoniae, H. influenzae and M. catarrhalis are the most common isolated bacteria. Amoxicillin (50 mg/kg/day) alone or with clavulanate is the first line antibiotic. Ceftriaxone (50 mg/kg/day) should be given to children who cannot take oral medications. Duration of the treatment varies from 10 to 28 days. The antibiotic may be changed if the symptoms get worse or do not improve within 72 hours (cefixime 8 mg/kg/day) [46].

AOM is an inflammatory disease of the middle ear involving the tympanic cavity frequently caused by S. pneumoniae, H. influenzae and M. catarrhalis . Diagnostic criteria for AOM are:

  • moderate to severe bulging of TM or new onset of othorrea not due to acute otitis externa;

  • mild bulging of the TM and recent onset of earache or intense erythema of the TM.

Pediatricians should prescribe antibiotics in children aged <6 months with both severe and moderate presentations, in children aged between 6 and 24 months with severe presentation in both unilateral and bilateral AOM or in those with moderate presentation in bilateral AOM. Children aged > 24 months need antibiotic therapy only when the presentation is severe [7, 8]. Amoxicillin (50 mg/kg/day) alone or with clavulanate is the first choice in moderate and severe presentation respectively. Alternative initial antibiotics include cefaclor (40-50 mg/kg/day) and cefuroxime-axetil (30 mg/kg/day) or cefpodoxima-proxetil (8 mg/kg/day) respectively. Ceftriaxone (50 mg/kg/day) can be given to children who cannot take oral medications or when the symptoms do not improve within 72 hours [9]. The duration of the treatment may vary from 5 to 10 days [8].

Most pharyngitis episodes are caused by viruses. Antibiotic therapy is recommended in every child with microbiologically documented group A β-hemolytic streptococcus pharyngitis (37%). The first-line treatment is amoxicillin (50 mg/kg/day for 10 days). In non-compliant cases, cefaclor (40 mg/kg/day) or cefuroxime-axetil (20-30 mg/kg/day) may be administrated [10].

Epiglottitis is a supraglottic laryngitis. It may be caused by S. pneumonia, S. aureus, β-hemolytic streptococcus and H. influenzae. The priority is airway management followed by antibiotic (ceftriaxone 50-75 mg/kg/day) treatment and steroids [11].

Authors’ Affiliations

(1)
Institute of Pediatrics, Catholic University of Sacred Heart, Rome, Italy
(2)
Campus Bio-Medico University, Rome, Italy

References

  1. Zeng L, Zhang L: Systematic review of evidence-based guidelines on medication therapy for upper respiratory tract infection in children with AGREE instrument. PLoS One. 2014, 9: e87711-10.1371/journal.pone.0087711.PubMedPubMed CentralView ArticleGoogle Scholar
  2. Hersh AL, Jackson MA, Hicks LA: Principles of judicious antibiotic prescribing for upper respiratory tract infections in pediatrics. Pediatrics. 2013, 132: 1146-1154. 10.1542/peds.2013-3260.PubMedView ArticleGoogle Scholar
  3. Perrott DA, Piira T, Goodenough B, Champion GD: Efficacy and safety of acetaminophen vs. ibuprofen for treating children's pain or fever. Arch Pediatr Adolesc Med. 2004, 158: 521-526. 10.1001/archpedi.158.6.521.PubMedView ArticleGoogle Scholar
  4. Hauk L: AAP releases guideline on diagnosis and management of acute bacterial sinusitis in children one to 18 years of age. Am Fam Physician. 2014, 89: 676-681.PubMedGoogle Scholar
  5. Wald ER, Applegate KE, Bordley C, Darrow DH, Glode MP, Marcy SM, et al: Clinical practice guideline for the diagnosis and management of acute bacterial sinusitis in children aged 1 to 18 years. Pediatrics. 2013, 132: e262-280. 10.1542/peds.2013-1071.PubMedView ArticleGoogle Scholar
  6. Maglietta V: Diagnosi e terapia pediatrica pratica. 2010, Rozzano (MI): Casa Editrice Ambrosiana, 10Google Scholar
  7. Lieberthal AS, Carroll AE, Chonmaitree T: The diagnosis and management of acute otitis media. Pediatrics. 2013, 131: e964-999. 10.1542/peds.2012-3488.PubMedView ArticleGoogle Scholar
  8. Thomas JP, Berner R, Zahnert T: Acute otitis media--a structured approach. Dtsch Arztebl Int. 2014, 111: 151-159.PubMedPubMed CentralGoogle Scholar
  9. Marchisio P, Principi N, Bellussi L: Otite media acuta: dalla diagnosi alla prevenzione. Linee guida della società italiana di Pediatria. 2010, Accessed at http://www.sip.it/documenti/otite.pdfGoogle Scholar
  10. Chiappini E, Principi N, Mansi N, Serra A, De Masi S, Camaioni A, et al: Italian Panel on the Management of Pharyngitis in Children. Management of acute pharyngitis in children: summary of the Italian National Institute of Health guidelines. Clin Ther. 2012, 34: 1442-1458. 10.1016/j.clinthera.2012.04.028.PubMedView ArticleGoogle Scholar
  11. Principi N, Marchisio PG, Esposito S, Pignataro L, Torretta S: Otorinolaringoiatria. Pediatria generale e specialistica. Edited by: Principi N, Rubino A, Vierucci A. 2012, Rozzano (MI): Casa Editrice Ambrosiana, 479-480. 1Google Scholar

Copyright

© Ferrara et al. 2015

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement